/주식/TKNO
TKNO

TKNO

USD

Alpha Teknova Inc. Common Stock

$6.490-0.060 (-0.916%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$6.550

고가

$6.570

저가

$6.310

거래량

0.00M

기업 기본 정보

시가총액

355.4M

산업

Drug Manufacturers - Specialty & Generic

국가

United States

거래 통계

평균 거래량

0.44M

거래소

NGM

통화

USD

52주 범위

저가 $1.155현재가 $6.490고가 $10.37

AI 분석 리포트

마지막 업데이트: 2025년 4월 26일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

TKNO: Alpha Teknova Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: TKNO Generate Date: 2025-04-26 11:48:34

Let's take a look at what's been happening with Alpha Teknova, TKNO, lately and try to figure out what the tea leaves might be suggesting.

Recent News Buzz

The main piece of news we've got is pretty straightforward: Teknova plans to announce their first quarter 2025 financial results on May 8th. This isn't earth-shattering news on its own, just a date for investors to mark on their calendars. Earnings reports are always a big deal, though, as they give us a peek into how the company is actually performing.

Now, digging a bit deeper into the sentiment data available, it seems the overall mood around TKNO is quite positive right now. There's talk of strong positive news sentiment out there, and notably, analysts are apparently feeling pretty good about the stock too, with a "Strong buy" rating from a couple of them and a price target way up at $11. That's a significant jump from where the stock is trading now.

Checking the Price Action

Looking back over the last month or so, TKNO's stock price has been on a bit of a rollercoaster. It started off higher, up around the $8 to $10 mark back in late January and early February. Then, things took a noticeable dip through February and into March, with the price dropping significantly, sometimes trading below $6.

More recently, though, it looks like the stock found its footing. Since late March and through April, we've seen a recovery. The price has been climbing back up, and the last recorded close was $6.49. This recent upward trend is a key point.

Comparing this to the AI's short-term view, the prediction for the next couple of days is for continued, albeit modest, upward movement. The AI sees potential gains of around 3.2% and 3.6% over the next two days.

Putting It All Together: Outlook & Ideas

So, what does this mix of news, price movement, and AI prediction suggest?

Based on the data right now, the situation seems to lean positive for TKNO in the near term. Here's why:

  1. Positive Sentiment: The strong positive news sentiment and analyst upgrades (with that high $11 target) are hard to ignore. This suggests there's some underlying optimism or positive developments circulating, even if the specific news provided is just an earnings date.
  2. Price Recovery: The stock has shown resilience by bouncing back from its recent lows. This upward trend suggests buying interest is returning.
  3. Upcoming Catalyst: The May 8th earnings report is a date to watch. Good results could fuel the positive sentiment and price trend further.
  4. AI Alignment: The AI's short-term prediction aligns with the recent upward price movement, suggesting the momentum might continue for a bit.

Given this picture, it might be a time where the situation favors potential buyers looking to ride this apparent positive wave.

Potential Entry Consideration: The recommendation data points to potential entry areas around $6.45 to $6.55. Since the last close was $6.49, the current price area looks like it falls right within this suggested window. Someone considering getting in might look at this range.

Potential Exit/Stop-Loss Consideration: Managing risk is always crucial. The recommendation data offers some potential levels here too. A possible stop-loss level to consider, perhaps to limit potential losses if the trend reverses unexpectedly, is $5.86. For those looking at potential profit targets based on this short-to-medium term view, the recommendation data suggests $7.27 as a take-profit level. Remember that analyst target of $11 is much higher and likely a longer-term goal.

Company Context

Just a quick reminder about Alpha Teknova itself: they operate in the Healthcare sector, specifically making critical reagents used in developing therapies, vaccines, and diagnostics. Think of them as providing essential ingredients for biotech and pharma companies. They are a smaller company, with a market cap around $355 million, which can sometimes mean the stock price might be more volatile than larger companies. Their P/E ratio is negative, which isn't unusual for companies in this growth-focused sector, but the recommendation data notes it's less negative than the industry average, which could be seen as a relative positive.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

GlobeNewswire

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies,

더 보기
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 27일 오후 08:47

약세중립강세

69.4% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$6.45

익절

$7.27

손절

$5.86

핵심 요소

PDI 16.7이(가) ADX 12.5과 함께 MDI 11.5 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($6.42) 근처에 있어 잠재적인 매수 기회를 나타냅니다.
거래량은 평균(6,617)의 1.5배로 시장 참여 증가를 나타냅니다.
MACD 0.0176이(가) 신호선 0.0107 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기